The Medicare Prescription Drug Rebate Rule PCMA Urges Congress to Permanently Repeal Rebate Rule This Year The Medicare Part D prescription drug benefit provides our nation’s seniors with affordable drug coverage, which is more important now than ever. The rebate
The Medicare Prescription Drug Rebate Rule The Medicare Part D prescription drug benefit provides our nation’s seniors with affordable drug coverage, which is more important now than ever. The rebate rule clumsily attempts to eliminate the primary tool used by
Lawmakers: Increase Competition In The Prescription Drug Market – Don’t Constrain It. S. 127, the “Pharmacy Benefit Manager Transparency Act of 2023” fundamentally misconstrues the role of pharmacy benefit companies, who are working every day to secure savings, enable better
Main Information On Tadalafil Principle of Action Tadalafil is the main active ingredient of Cialis, one of the most popular drugs for erectile dysfunction (ED) today. This substance is responsible for the effect of Cialis on the male body. How
(Washington, D.C.) — FMI – The Food Industry Association, the National Association of Chain Drug Stores (NACDS), National Community Pharmacists Association (NCPA), National Grocers Association (NGA), and the Pharmaceutical Care Management Association (PCMA) today issued the following joint statement outlining
PBMs: Committed to Helping Patients The Critical Path Forward: Rx Policies to Reduce Patient Costs, Improve Access For America’s pharmacy benefit managers, PBMs, our core mission is to increase access to affordable prescription drugs for all Americans. But more can
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today issued the following statement on litigation, filed in the U.S. District Court of the District of Columbia, regarding the Trump administration’s final rule Transparency in Coverage: To avoid higher prescription drug costs for
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) Chief Policy and External Affairs Officer Kristin Bass released the following statement on the legislative markup on prescription drug pricing legislation by the U.S. Senate Committee on the Judiciary. “We applaud members
©2022 PCMA. All Rights Reserved.
